{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicjebqxnmyfbg3erzbfn6xujk3wl2allgykhf6kh2fwooq2hfp2uu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mof27maa76j2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidwlrkgwzr2nslvvfdbfvevnhbl2mkvip3sbdptk7sj6xkklsar34"
    },
    "mimeType": "image/jpeg",
    "size": 167421
  },
  "path": "/news/2026-06-psilocybin-persistent-concussion-symptoms-australia.html",
  "publishedAt": "2026-06-15T23:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Monash University researchers have launched Australia's first clinical trial to test whether the psychedelic drug psilocybin is an effective treatment for persistent post-concussion symptoms.",
  "title": "Psilocybin to target persistent concussion symptoms in Australia's first clinical trial"
}